Dr Reddys Laboratories (RDY) Profit After Tax (2009 - 2023)
Dr Reddys Laboratories (RDY) posted quarterly Profit After Tax of $170.0 million for Q2 2023, down 1.16% quarter-over-quarter from $172.0 million in Q1 2023.
Dr Reddys Laboratories (RDY) Profit After Tax (2009 - 2023) Analysis & Trends
Dr Reddys Laboratories' Profit After Tax history runs 15 years deep, the most recent figure standing at $170.0 million for Q2 2023.
- In Q2 2023, Profit After Tax changed N/A year-over-year to $170.0 million; the TTM figure through Jun 2023 stood at $459.0 million (changed N/A YoY), while the FY2026 annual figure was $452.0 million, down 32.64% from the prior year.
- Profit After Tax for Q2 2023 stood at $170.0 million, down from $172.0 million in the prior quarter.
- The five-year high for Profit After Tax was $172.0 million in Q1 2023, with the low at -$78.0 million in Q3 2020.
- The 5-year median for Profit After Tax is $110.5 million (2019), against an average of $92.8 million.
- The sharpest annual moves came in 2019 and 2020: Profit After Tax surged 131.82% in 2019, then slumped 214.71% in 2020.
- Dr Reddys Laboratories' Profit After Tax stood at $68.0 million in 2019, then plunged by 214.71% to -$78.0 million in 2020, then soared by 271.79% to $134.0 million in 2021, then slipped by 12.69% to $117.0 million in 2022, then surged by 45.3% to $170.0 million in 2023.
- Business Quant data shows RDY's Profit After Tax at $170.0 million in Q2 2023, $172.0 million in Q1 2023, and $117.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 501,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 170.00 Mn |
| Mar 31, 2023 | 172.00 Mn |
| Dec 31, 2022 | 117.00 Mn |
| Sep 30, 2022 | 152.00 |
| Jun 30, 2021 | 134.00 Mn |
| Mar 31, 2021 | 77.00 Mn |
| Sep 30, 2020 | -78.00 Mn |
| Jun 30, 2020 | 104.00 Mn |
| Mar 31, 2020 | 79.00 Mn |
| Sep 30, 2019 | 68.00 Mn |
| Jun 30, 2019 | 153.00 Mn |
| Mar 31, 2019 | 117.00 Mn |
| Dec 31, 2018 | 63.00 Mn |
| Sep 30, 2018 | 70.00 Mn |
| Jun 30, 2018 | 66.00 Mn |
| Mar 31, 2018 | 63.00 Mn |
| Dec 31, 2017 | 44.00 Mn |
| Sep 30, 2017 | 53.00 Mn |
| Dec 31, 2016 | 22.00 Mn |
| Sep 30, 2016 | 86.00 Mn |